Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001863113-21-000002

Options or other derivatives

  • CFO, Secretary, Treasurer acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Bregman Marc CFO, Secretary, Treasurer 2021-05-17 Grant or award · Options +300,000 $0.06 $16,860 300,000 D
Loading xslF345X03/primary_doc.xml…